On January 3rd the Wellcome Trust launched a new healthcare venture capital fund through a subsidiary investment company, Syncona Partners LLP (“Syncona”). Syncona is looking to develop a portfolio of investments in healthcare devices, diagnostics, therapeutics, information technology, and services. Syncona will support early- and late-stage companies, as a majority investor or as part of a syndicate. Syncona has starting capital of £200 million and will be looking to support investments between £1m and £20m to support the creation of sustainable healthcare businesses.
Further information is at http://www.wellcome.ac.uk/News/Media-office/Press-releases/2013/WTP041359.htm.
